UZ Gasthuisberg

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Chronic lymphocytic leukaemia1 trial
• Diffuse large B-cell lymphoma1 trial
• Dystonia1 trial
• Essential tremor1 trial
• Parkinson disease1 trial

Phase

• Phase 32 trials

Status

• Completed2 trials
• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Boston Scientific Corporation3 trials
• German CLL Study Group1 trial
• Kite, A Gilead Company1 trial

Running trials

• Recruiting

  Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET)

  NCT04032470· Boston Scientific Corporation· Source

  Contact: Boston Scientific Clinical Research

• Recruiting

  Vercise™ DBS Dystonia Prospective Study

  NCT02686125· Boston Scientific Corporation· Source

  Contact: Boston Scientific Clinical Research

• Recruiting

  Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

  NCT02071134· Boston Scientific Corporation· Source

  Contact: Heleen Scholtes

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Dystonia1 recruiting
• Essential tremor1 recruiting

Closed trials

• Completed

  Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma

  NCT03391466· Phase 3· Kite, A Gilead Company· Source

• Completed

  Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation

  NCT02950051· Phase 3· German CLL Study Group· Source